U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07783594) titled 'Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma' on Aug. 21.
Brief Summary: To compare the time to next treatment between patients with previously untreated, low tumor burden FL who receive the study drug epcoritamab versus those who do not receive epcoritamab and are monitored only.
Study Start Date: Feb. 12, 2027
Study Type: INTERVENTIONAL
Condition:
Randomized
Phase 2
Epcoritamab
Watch & Wait
Untreated
Tumor Burden
Follicular Lymphoma
Intervention:
DRUG: Epcoritamab
Given by Injection
OTHER: Observation
Participant will be closely monitore...